Overview
What is The Fibrolamellar Cancer Foundation?
The Fibrolamellar Cancer Foundation is a nonprofit organization situated in Greenwich, Connecticut. Established to raise awareness and financial support for Fibrolamellar Carcinoma, a rare form of liver cancer predominantly affecting adolescents and young adults, the foundation currently lacks viable treatment options beyond liver resection surgery. The organization's mission is twofold: to discover a cure and reliable treatment options for those diagnosed with this disease and foster better communication between healthcare professionals and patients. With a team of three dedicated individuals, the foundation grants funds to research organizations to further their studies on Fibrolamellar Carcinoma.
Official website here: www.fibrofoundation.org
Is The Fibrolamellar Cancer Foundation legitimate?
The Fibrolamellar Cancer Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Fibrolamellar Cancer Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $200,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $286,543
For more financial information, click here
Official website here: www.fibrofoundation.org
What is the mission statement of The Fibrolamellar Cancer Foundation?
The Fibrolamellar Cancer Foundation was established with a mission to increase awareness and fund research for Fibrolamellar Carcinoma, a rare form of liver cancer predominantly affecting adolescents and young adults. Currently, there are limited treatment options beyond liver resection surgery. The foundation's goal is to discover a cure and reliable treatment options for those diagnosed with this rare disease. Additionally, the foundation aims to improve communications among healthcare professionals and patients associated with Fibrolamellar Carcinoma.
Official website here: www.fibrofoundation.org
Who is the CEO of The Fibrolamellar Cancer Foundation?
Kurt Losert is the Co-Chairperson of The Fibrolamellar Cancer Foundation. The CEO's salary of The Fibrolamellar Cancer Foundation is $0 and their total compensation is $0.
Official website here: www.fibrofoundation.org
What is the revenue of The Fibrolamellar Cancer Foundation?
The Fibrolamellar Cancer Foundation's revenue in 2022 was $6,076,635.
Official website here: www.fibrofoundation.org
Who are the executives of The Fibrolamellar Cancer Foundation and what are their salaries?
The average compensation at The Fibrolamellar Cancer Foundation during 2022 was $162,181. There are 3 employees and 50 volunteers at The Fibrolamellar Cancer Foundation.
Here are 12 key members and their salaries (The Fibrolamellar Cancer Foundation's CEO's salary is $0 and their total compensation is $0):
- John Hopper (President (Thru 9/30/22))
- Dr Mark Furth (Scientific Director)
- Marna O Davis (Co-Chairperson) [Trustee/Director]
- Charles W Beerman (Director)
- Derek Gilchrist (Director, Secretary)
- Anne Adler (Director)
- John Craig (Director)
- Tal Friedman (Director)
- Charles A Davis (Co-Chairperson) [Trustee/Director]
- Leslie Graves (Treasurer) [Trustee/Director]
- Craig Martin (Director)
- Kurt Losert (Ceo (From 10/4/22)) [Trustee/Director]
Official website here: www.fibrofoundation.org
Where can I find the form 990 for The Fibrolamellar Cancer Foundation?
The The Fibrolamellar Cancer Foundation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.fibrofoundation.org
Learn more at the official website: www.fibrofoundation.org
Mission Statement of The Fibrolamellar Cancer Foundation
The Fibrolamellar Cancer Foundation, established with the aim to raise awareness and research funds for Fibrolamellar carcinoma, a rare form of liver cancer predominantly affecting teens and young adults, has a mission to find a cure and reliable treatment options for those diagnosed with this disease. Currently, the only viable treatment option is liver resection surgery. The foundation's objective extends beyond medical advancements, aiming to enhance communications among healthcare professionals and patients, fostering a collaborative approach in the battle against this rare disease.
Impact
This information is meant to be a general summary of The Fibrolamellar Cancer Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Fibrolamellar Cancer Foundation's impact is significant in the fight against fibrolamellar carcinoma, a rare form of liver cancer primarily affecting teens and young adults. With a mission to raise awareness and research funds for this disease, the Foundation aims to find a cure and develop reliable treatment options beyond liver resection surgery. By granting funds to research organizations conducting studies on fibrolamellar carcinoma, the Foundation is actively working towards enhancing communications between healthcare professionals and patients to improve outcomes for those diagnosed with this rare and challenging disease.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2009
Phone
(203) 862-3196
Principal Officer
Kurt Losert
Main Address
20 HORSENECK LANE 2ND FLOOR, GREENWICH, CT, 06830
Website
www.fibrofoundation.org
NTEE Category
Code: G193 - Disease
If you are a representative of The Fibrolamellar Cancer Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.